WUXI LIFE (08148) announces a profitable year, with an expected net profit attributable to shareholders for 2025 not less than approximately 6.5 million Hong Kong dollars, turning losses into gains compared to the previous year.
Aviva Life (08148) announces that the group expects to achieve a net profit attributable to owners of about HK$6.5 million for the year ending December 31, 2025 (2025 financial year), compared to a net loss of about HK$5.5 million for the year ending December 31, 2024 (2024 financial year). The board of directors anticipates a turnaround from loss to profit, with the increase in gross profit mainly due to (i) higher revenue from software platform business in Hong Kong in 2025 compared to 2024; and (ii) higher revenue from product sales business and advertising e-commerce and supply chain management services business in China in 2025 compared to 2024.
WUXI LIFE (08148) announced that the group is expected to achieve a profit attributable to owners of the company of not less than approximately HK$6.5 million for the financial year ending on December 31, 2025 (2025 financial year), compared to a loss attributable to owners of the company of approximately HK$5.5 million for the financial year ended on December 31, 2024 (2024 financial year). The board of directors expects to turn the loss into a profit, with the increase in gross profit mainly due to (i) higher revenue from the software platform business in Hong Kong in the 2025 financial year compared to the 2024 financial year; and (ii) higher revenue from product sales business and advertising e-commerce and supply chain management services business in China in the 2025 financial year compared to the 2024 financial year.
Related Articles

EAST BUY (01797) issued a total of 5.4697 million shares under the stock incentive plan.

Pfizer Inc. (PFE.US) achieves primary endpoint with potential "first-in-class" small molecule combination therapy.

FIRST SERVICE (02107) is expected to incur a net loss of no more than 53 million yuan for the year.
EAST BUY (01797) issued a total of 5.4697 million shares under the stock incentive plan.

Pfizer Inc. (PFE.US) achieves primary endpoint with potential "first-in-class" small molecule combination therapy.

FIRST SERVICE (02107) is expected to incur a net loss of no more than 53 million yuan for the year.

RECOMMEND

European Carmakers Embrace China: Under Technology And Cost Pressure, Stellantis And Mercedes Seek Partnerships With Chinese Automakers
17/03/2026

HKEX Listing Mechanism Reform Revisited: How To Balance New Favorites And Established Names
17/03/2026

International Oil Prices Plunge Boosts U.S. Stocks; Morgan Stanley Chief Says Market Correction Nearing End
17/03/2026


